Sort
82,697 grants matching “vaccine development”
Arming the Immune System Against Pathogens
$4,457,415Laurie H Glimcher · Harvard School Of Public Health · P01 · FY2006 · AI
Safeguard the household: comprehensive AIDS research
$4,456,905Wits Health Consortium (Pty), Ltd · U19 · FY2004 · AI
Defining signatures for immune responsiveness by functional systems immunology
$4,456,091David A. Hafler · Yale University · U19 · FY2010 · AI
NEW HORIZONS IN THE PREVENTION AND TREATMENT OF FOOD ALLERGY
$4,455,000Robert A Wood · Johns Hopkins University · UM2 · FY2017 · AI
Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats
$4,452,397Kartik Chandran · Albert Einstein College Of Medicine · U19 · FY2020 · AI
Natural History of AIDS in Homosexual Men
$4,448,266Roger Detels · University Of California Los Angeles · U01 · FY2015 · AI
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$4,443,970Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2024 · AI
PRECLINICAL DEVELOPMENT OF A BALANCED, TETRAVALENT, LIVE-ATTENUATED VACCINE AGAINST THE FOUR DENGUE VIRUS SEROTYPES
$4,443,544Codagenix Inc · · FY2022 · Defense Health Agency
SDSU FUERTE: Administrative Core
$4,441,253Mark Brian Reed · San Diego State University · U54 · FY2024 · CA
The WWAMI RCE for Biodefense and Emerging ID
$4,440,215University Of Washington · U54 · FY2003 · AI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention
$4,434,672Marc Michael Baum · Oak Crest Institute Of Science · U19 · FY2016 · AI
EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)
$4,433,477Marianne Ward · Duke University · N01 · FY2017 · AI
Development of Technologies that Accelerate the Immune Response to Vaccines
$4,427,541Paul Chaplin · Bavarian Nordic A/S · N01 · FY2012 · AI
Natural History of AIDS in Homosexual Men
$4,423,916Roger Detels · University Of California Los Angeles · U01 · FY2014 · AI
I4C 2.0: Immunotherapy for Cure
$4,423,055Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2024 · AI
Synthetic DNA-launched and adjuvanted Env immunogens for HIV
$4,420,687David B. Weiner · Wistar Institute · U19 · FY2024 · AI
San Francisco Bay Clinical Trials Unit
$4,418,930Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2014 · AI
EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)
$4,417,247Marianne Ward · Duke University · N01 · FY2018 · AI
SDMC: HIV Vaccine Trials Network
$4,411,693Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
SDSU FUERTE: Administrative Core
$4,403,019Mark Brian Reed · San Diego State University · U54 · FY2023 · CA
SDSU FUERTE: Administrative Core
$4,402,042Mark Brian Reed · San Diego State University · U54 · FY2022 · CA
Systems Biological Analysis of Innate and Adaptive Responses to Vaccination
$4,398,252Bali Pulendran · Emory University · U19 · FY2011 · AI
Development of rationally designed HIV vaccines
$4,395,296Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program
$4,394,852Karran Phillips · National Institute On Drug Abuse · ZID · FY2019 · DA
Durable Antibody Mediated Protection Against HIV
$4,394,406Robert C Gallo · University Of Maryland Baltimore · P01 · FY2017 · AI